These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21542797)

  • 1. Advanced mass spectrometry-based methods for the analysis of conformational integrity of biopharmaceutical products.
    Bobst CE; Kaltashov IA
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1517-29. PubMed ID: 21542797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MS-based conformation analysis of recombinant proteins in design, optimization and development of biopharmaceuticals.
    Goswami D; Zhang J; Bondarenko PV; Zhang Z
    Methods; 2018 Jul; 144():134-151. PubMed ID: 29678586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.
    Kaltashov IA; Bobst CE; Abzalimov RR; Berkowitz SA; Houde D
    J Am Soc Mass Spectrom; 2010 Mar; 21(3):323-37. PubMed ID: 19963397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based methods in characterization of the higher order structure of protein therapeutics.
    Kaltashov IA; Bobst CE; Pawlowski J; Wang G
    J Pharm Biomed Anal; 2020 May; 184():113169. PubMed ID: 32092629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.
    Kaltashov IA; Bobst CE; Abzalimov RR; Wang G; Baykal B; Wang S
    Biotechnol Adv; 2012; 30(1):210-22. PubMed ID: 21619926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher order structure characterization of protein therapeutics by hydrogen/deuterium exchange mass spectrometry.
    Huang RY; Chen G
    Anal Bioanal Chem; 2014 Oct; 406(26):6541-58. PubMed ID: 24948090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterization of altered conformations of protein pharmaceuticals using complementary mass spectrometry-based approaches.
    Bobst CE; Abzalimov RR; Houde D; Kloczewiak M; Mhatre R; Berkowitz SA; Kaltashov IA
    Anal Chem; 2008 Oct; 80(19):7473-81. PubMed ID: 18729476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen/deuterium exchange-mass spectrometry analysis of high concentration biotherapeutics: application to phase-separated antibody formulations.
    Tian Y; Huang L; Ruotolo BT; Wang N
    MAbs; 2019; 11(4):779-788. PubMed ID: 30890021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Utilization of Hydrogen/Deuterium Exchange in Biopharmaceutical Industry].
    Coufalová D; Vojtěšek B; Hernychova L
    Klin Onkol; 2016; 29 Suppl 4(Suppl 4):59-63. PubMed ID: 27846722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of stress-exposed granulocyte colony stimulating factor using ELISA and hydrogen/deuterium exchange mass spectrometry.
    Tsuchida D; Yamazaki K; Akashi S
    J Am Soc Mass Spectrom; 2014 Oct; 25(10):1747-54. PubMed ID: 25070584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using hydrogen/deuterium exchange mass spectrometry to study conformational changes in granulocyte colony stimulating factor upon PEGylation.
    Wei H; Ahn J; Yu YQ; Tymiak A; Engen JR; Chen G
    J Am Soc Mass Spectrom; 2012 Mar; 23(3):498-504. PubMed ID: 22227798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Aggregation Propensity of a Human Fc-Fusion Protein Therapeutic by Hydrogen/Deuterium Exchange Mass Spectrometry.
    Huang RY; Iacob RE; Krystek SR; Jin M; Wei H; Tao L; Das TK; Tymiak AA; Engen JR; Chen G
    J Am Soc Mass Spectrom; 2017 May; 28(5):795-802. PubMed ID: 27527097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopharmaceutical quality control with mass spectrometry.
    Liu S; Schulz BL
    Bioanalysis; 2021 Aug; 13(16):1275-1291. PubMed ID: 34463131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational Assessment of Adnectin and Adnectin-Drug Conjugate by Hydrogen/Deuterium Exchange Mass Spectrometry.
    Huang RY; O'Neil SR; Lipovšek D; Chen G
    J Am Soc Mass Spectrom; 2018 Jul; 29(7):1524-1531. PubMed ID: 29736601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution MS for structural characterization of protein therapeutics: advances and future directions.
    Wei H; Tymiak AA; Chen G
    Bioanalysis; 2013 May; 5(10):1299-313. PubMed ID: 23721450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Hydrogen/Deuterium Exchange Mass Spectrometry and the Pursuit of Challenging Biological Systems.
    James EI; Murphree TA; Vorauer C; Engen JR; Guttman M
    Chem Rev; 2022 Apr; 122(8):7562-7623. PubMed ID: 34493042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mass spectrometry in the characterization of biologic protein products.
    Rathore D; Faustino A; Schiel J; Pang E; Boyne M; Rogstad S
    Expert Rev Proteomics; 2018 May; 15(5):431-449. PubMed ID: 29694790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid-phase separations coupled with ion mobility-mass spectrometry for next-generation biopharmaceutical analysis.
    Makey DM; Ruotolo BT
    Expert Rev Proteomics; 2024; 21(5-6):259-270. PubMed ID: 38934922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development - A review.
    Deng B; Lento C; Wilson DJ
    Anal Chim Acta; 2016 Oct; 940():8-20. PubMed ID: 27662755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications.
    Wei H; Mo J; Tao L; Russell RJ; Tymiak AA; Chen G; Iacob RE; Engen JR
    Drug Discov Today; 2014 Jan; 19(1):95-102. PubMed ID: 23928097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.